Literature DB >> 32621581

Narcolepsy risk and COVID-19.

Emmanuel Mignot1, Steve Black2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32621581      PMCID： PMC7954017          DOI： 10.5664/jcsm.8668

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  16 in total

1.  Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting.

Authors:  Kathryn Edwards; Germaine Hanquet; Steve Black; Emmanuel Mignot; Christopher Jankosky; Tom Shimabukuro; Elizabeth Miller; Hanna Nohynek; Pieter Neels
Journal:  Biologicals       Date:  2019-05-23       Impact factor: 1.856

2.  Narcolepsy and COVID-19: sleeping on an opportunity?

Authors:  Fabian-Xosé Fernandez; Julie Flygare; Michael A Grandner
Journal:  J Clin Sleep Med       Date:  2020-08-15       Impact factor: 4.062

3.  Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development.

Authors:  Louis Jacob; Ryan Leib; Hanna M Ollila; Mélodie Bonvalet; Christopher M Adams; Emmanuel Mignot
Journal:  Brain Behav Immun       Date:  2014-11-15       Impact factor: 7.217

Review 4.  Autoimmune sleep disorders.

Authors:  Michael H Silber
Journal:  Handb Clin Neurol       Date:  2016

5.  Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases.

Authors:  Guo Luo; Ling Lin; Louis Jacob; Mélodie Bonvalet; Aditya Ambati; Giuseppe Plazzi; Fabio Pizza; Ryan Leib; Christopher M Adams; Markku Partinen; Emmanuel Jean-Marie Mignot
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

Review 6.  The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.

Authors:  Félix A Rey; Karin Stiasny; Marie-Christine Vaney; Mariano Dellarole; Franz X Heinz
Journal:  EMBO Rep       Date:  2017-12-27       Impact factor: 8.807

7.  Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.

Authors:  Guo Luo; Aditya Ambati; Ling Lin; Mélodie Bonvalet; Markku Partinen; Xuhuai Ji; Holden Terry Maecker; Emmanuel Jean-Marie Mignot
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-12       Impact factor: 11.205

Review 8.  Parkinson disease and the immune system - associations, mechanisms and therapeutics.

Authors:  Eng-King Tan; Yin-Xia Chao; Andrew West; Ling-Ling Chan; Werner Poewe; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2020-04-24       Impact factor: 42.937

Review 9.  Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant-Antigen Codelivery.

Authors:  Zhi-Biao Wang; Jing Xu
Journal:  Vaccines (Basel)       Date:  2020-03-13

10.  In vivo clonal expansion and phenotypes of hypocretin-specific CD4+ T cells in narcolepsy patients and controls.

Authors:  Wei Jiang; James R Birtley; Shu-Chen Hung; Weiqi Wang; Shin-Heng Chiou; Claudia Macaubas; Birgitte Kornum; Lu Tian; Huang Huang; Lital Adler; Grant Weaver; Liying Lu; Alexandra Ilstad-Minnihan; Sriram Somasundaram; Sashi Ayyangar; Mark M Davis; Lawrence J Stern; Elizabeth D Mellins
Journal:  Nat Commun       Date:  2019-11-20       Impact factor: 14.919
View more
  1 in total

1.  COVID-19 Vaccine Could Trigger the Relapse of Secondary Hypersomnia.

Authors:  Min Wu; Shirley Xin Li; Pei Xue; Junying Zhou; Xiangdong Tang
Journal:  Nat Sci Sleep       Date:  2021-12-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.